Clinical Trial Update: Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating standardized olive extract on bone turnover markers in postmenopausal women with osteoporosis or osteopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Standardized Olive Extract (Olea europaea extract)

Snippet

Sponsor: BioActor | Conditions: Osteoporosis, Osteopenia | Phase 2 | Status: COMPLETED